Bysiek A

Unit II, Department of Pharmacology and Brain Biostructure, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Kraków, Smętna, Poland.

8 papers · 1 preprint · ORCID

ArticlePsilocybin

Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats.

Bysiek A, Szpręgiel I, Wojtas A +8

Europe PMC2026
ArticlePsilocybin

The effect of psilocin on neurotransmitters release in the claustrum and on rat behavior.

Kościuk Z, Szpręgiel I, Bysiek A +1

Europe PMC2026
ArticlePsilocybin

Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamus.

Pałasz A, Pukowiec M, Bogus K +8

Europe PMC2025
ArticlePsilocybin

The effect of low-dose psilocybin on brain neurotransmission and rat behavior.

Bysiek A, Wojtas A, Szpręgiel I +3

Europe PMC2025
ArticlePsilocybin

Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases.

Szpręgiel I, Bysiek A

Europe PMC2024
ArticlePsilocybin

Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study.

Wojtas A, Bysiek A, Wawrzczak-Bargiela A +2

Europe PMC2023
PreprintPsilocybin

Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study

Wojtas A, Bysiek A, Wawrzczak-Bargiela A +2

Europe PMC2023
ArticlePsilocybin

Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior.

Wojtas A, Bysiek A, Wawrzczak-Bargiela A +5

Europe PMC2022
ArticlePsychedelics

Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe.

Herian M, Wojtas A, Maćkowiak M +5

Europe PMC2022